NASDAQ:ATHN - athenahealth Stock Price, Price Target & More

Get Started

$153.19 -0.26 (-0.17 %)

(As of 05/25/2018 04:00 PM ET)

Previous Close$153.19

Today's Range$152.6150 - $154.3875

52-Week Range$111.61 - $158.66

Volume166,700 shs

Average Volume538,549 shs

Market Capitalization$6.21 billion

P/E Ratio97.57

Dividend YieldN/A

Beta1.16

About athenahealth (NASDAQ:ATHN)

athenahealth, Inc., together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services. The company also provides athenahealth Population Health, a cloud-based population health service; and Epocrates services that include clinical information and decision support services in the areas of drug and disease information, medical calculator and tools, clinical guidelines, clinical messaging, and market research. In addition, it offers athenahealth Health Plan data exchange facilitates to exchange the data between providers and health plans for the healthcare operations of clients; athenaOne Analytics that includes an analytics and dashboard application, as well as provides visibility into the financial and operational health of an organization; and pre-certification processing and referral processing services. The company serves healthcare providers, medical groups, and health systems through its direct sales force and channel partners in the United States and internationally. athenahealth, Inc. was formerly known as athenahealth.com, Inc. and changed its name to athenahealth, Inc. in November 2000. The company was founded in 1997 and is headquartered in Watertown, Massachusetts.

Receive ATHN News and Ratings via Email

Sign-up to receive the latest news and ratings for ATHN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Business services, not elsewhere classified

Sub-IndustryHealth Care Technology

SectorMedical

SymbolNASDAQ:ATHN

CUSIP04685W10

Webwww.athenahealth.com

Phone617-402-1000

Debt

Debt-to-Equity Ratio0.25

Current Ratio2.71

Quick Ratio2.71

Price-To-Earnings

Trailing P/E Ratio97.57

Forward P/E Ratio52.46

P/E Growth2.85

Sales & Book Value

Annual Sales$1.22 billion

Price / Sales5.07

Cash Flow$5.2661 per share

Price / Cash29.09

Book Value$24.09 per share

Price / Book6.36

Profitability

EPS (Most Recent Fiscal Year)$1.57

Net Income$53.10 million

Net Margins6.77%

Return on Equity13.01%

Return on Assets7.91%

Miscellaneous

Employees5,156

Outstanding Shares40,410,000

athenahealth (NASDAQ:ATHN) Frequently Asked Questions

What is athenahealth's stock symbol?

athenahealth trades on the NASDAQ under the ticker symbol "ATHN."

How were athenahealth's earnings last quarter?

athenahealth (NASDAQ:ATHN) announced its earnings results on Thursday, April, 26th. The health services provider reported $1.25 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.72 by $0.53. The health services provider had revenue of $329.40 million for the quarter, compared to analyst estimates of $318.13 million. athenahealth had a net margin of 6.77% and a return on equity of 13.01%. athenahealth's quarterly revenue was up 15.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.32 earnings per share. View athenahealth's Earnings History.

When is athenahealth's next earnings date?

athenahealth is scheduled to release their next quarterly earnings announcement on Wednesday, July, 18th 2018. View Earnings Estimates for athenahealth.

What price target have analysts set for ATHN?

25 equities research analysts have issued 1 year target prices for athenahealth's stock. Their forecasts range from $125.00 to $184.00. On average, they anticipate athenahealth's stock price to reach $152.6364 in the next twelve months. View Analyst Ratings for athenahealth.

What are Wall Street analysts saying about athenahealth stock?

Here are some recent quotes from research analysts about athenahealth stock:

1. Cantor Fitzgerald analysts commented, "Technology strategy evolving. After its analyst meeting in February, our sense was that the company was trying to add more capabilities to its platform in order to create more value for existing clients. It appears as though the strategy is far more complicated as the company is attempting to move from a monolithic platform" to provide micro-services". In essence, the company will attempt to unbundle its services and allow providers to use these services on an incremental basis. This development work has been underway for some time now. The company was reluctant to commit to when the micro-services" will be commercially available. But the transition is an important component of the company’s future growth strategy." (5/14/2018)
2. Canaccord Genuity analysts commented, "We remain neutral on the stock until we get a better understanding of the restructuring initiatives, financial predictability, and the go-forward growth strategy. Pre-call takeaways: Upside to revenue, with significant bottom-line beat. Rev. of $329.2M (+14.2%) beat our est. $324.8M and cons. $320.0M, and came in at the high end of implied guidance range $309-$329M. Beats on adjusted gross margin and all expense line items enabled the company to post non-GAAP op. inc. of $77.6M (+82.6%), far surpassing us and cons. both near ~$45M and implied guidance of $38-53M. Adj-EPS of $1.11 also beat our est. $0.65 and cons. $0.63." (2/1/2018)

Who are some of athenahealth's key competitors?

Some companies that are related to athenahealth include Ctrip.Com International (CTRP), First Data (FDC), Fleetcor (FLT), Global Payments (GPN), TSYS (TSS), Worldpay (WP), MSCI (MSCI), CoStar Group (CSGP), Broadridge Financial Solutions (BR), Mercadolibre (MELI), Akamai Technologies (AKAM), Cielo (CIOXY), Alliance Data (ADS), Nielsen (NLSN) and Zillow (Z).

Who are athenahealth's key executives?

athenahealth's management team includes the folowing people:

Mr. Jonathan J. Bush, Pres, CEO & Director (Age 49)
Mr. Timothy John O'Brien, Sr. VP of Commercial Operations & Chief Marketing Officer (Age 42)
Dr. Stephen N. Kahane M.D., M.S, Exec. Director of Client Organization (Age 60)
Mr. Marc A. Levine, Exec. VP, CFO, Treasurer & Principal Accounting Officer (Age 58)
Mr. Prakash Khot, Exec. VP & CTO (Age 48)

Has athenahealth been receiving favorable news coverage?

Media coverage about ATHN stock has trended somewhat positive on Friday, Accern Sentiment Analysis reports. The research group identifies negative and positive media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. athenahealth earned a daily sentiment score of 0.12 on Accern's scale. They also gave press coverage about the health services provider an impact score of 46.66 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Who are athenahealth's major shareholders?

athenahealth's stock is owned by many different of retail and institutional investors. Top institutional investors include FMR LLC (6.20%), BlackRock Inc. (4.15%), ELLIOTT ASSOCIATES, L.P. (1.40%), Sumitomo Mitsui Trust Holdings Inc. (1.39%), Allianz Asset Management GmbH (0.99%) and Allianz Asset Management GmbH (0.99%). Company insiders that own athenahealth stock include Amy Abernethy, Bradford Kyle Armbrester, Brandon H Hull, Daniel P Haley, David Eric Robinson, Ed Park, Jeffrey R Immelt, John A Kane, Jonathan Bush, Jonathan D Porter, Karl Stubelis and Timothy John O'brien. View Institutional Ownership Trends for athenahealth.

Which major investors are selling athenahealth stock?

ATHN stock was sold by a variety of institutional investors in the last quarter, including Allianz Asset Management GmbH, Allianz Asset Management GmbH, Toronto Dominion Bank, Zurcher Kantonalbank Zurich Cantonalbank, Sei Investments Co., Hsbc Holdings PLC, A.R.T. Advisors LLC and Envestnet Asset Management Inc.. Company insiders that have sold athenahealth company stock in the last year include Amy Abernethy, Bradford Kyle Armbrester, Brandon H Hull, Daniel P Haley, David Eric Robinson, Jonathan Bush, Jonathan D Porter, Karl Stubelis and Timothy John O'brien. View Insider Buying and Selling for athenahealth.

Which major investors are buying athenahealth stock?

ATHN stock was purchased by a variety of institutional investors in the last quarter, including Millennium Management LLC, Summit Trail Advisors LLC, Natixis, Victory Capital Management Inc., Federated Investors Inc. PA, Wells Fargo & Company MN, Prudential Financial Inc. and Kornitzer Capital Management Inc. KS. View Insider Buying and Selling for athenahealth.

How do I buy shares of athenahealth?

Shares of ATHN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is athenahealth's stock price today?

One share of ATHN stock can currently be purchased for approximately $153.19.

How big of a company is athenahealth?

athenahealth has a market capitalization of $6.21 billion and generates $1.22 billion in revenue each year. The health services provider earns $53.10 million in net income (profit) each year or $1.57 on an earnings per share basis. athenahealth employs 5,156 workers across the globe.

How can I contact athenahealth?

athenahealth's mailing address is 311 ARSENAL STREET, WATERTOWN MA, 02472. The health services provider can be reached via phone at 617-402-1000 or via email at [email protected]

MarketBeat Community Rating for athenahealth (ATHN)

Community Ranking:		2.4 out of 5 ( )
Outperform Votes:		543 (Vote Outperform)
Underperform Votes:		608 (Vote Underperform)
Total Votes:		1,151

MarketBeat's community ratings are surveys of what our community members think about athenahealth and other stocks. Vote "Outperform" if you believe ATHN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATHN will underperform the S&P 500 over the long term. You may vote once every thirty days.

athenahealth (NASDAQ:ATHN) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

25 Wall Street analysts have issued ratings and price targets for athenahealth in the last 12 months. Their average twelve-month price target is $152.6364, suggesting that the stock has a possible downside of 0.36%. The high price target for ATHN is $184.00 and the low price target for ATHN is $125.00. There are currently 17 hold ratings and 8 buy ratings for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Hold	Hold
Consensus Rating Score:	2.32	2.24	2.25	2.40
Ratings Breakdown:	0 Sell Rating(s) 17 Hold Rating(s) 8 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 17 Hold Rating(s) 7 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 16 Hold Rating(s) 7 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 13 Hold Rating(s) 11 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$152.6364	$145.3478	$144.2273	$143.2174
Price Target Upside:	0.36% downside	1.46% upside	2.12% upside	16.58% upside

athenahealth (NASDAQ:ATHN) Consensus Price Target History

Price Target History for athenahealth (NASDAQ:ATHN)

athenahealth (NASDAQ:ATHN) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/22/2018	Deutsche Bank	Boost Price Target	Hold ➝ Hold	$160.00 ➝ $170.00	Low
5/17/2018	Jefferies Group	Set Price Target	Hold	$160.00	Low
5/17/2018	Royal Bank of Canada	Reiterated Rating	Hold	$160.00	Low
5/15/2018	Berenberg Bank	Downgrade	Buy ➝ Hold	$143.00 ➝ $163.00	Low
5/14/2018	Cantor Fitzgerald	Reiterated Rating	Hold	$140.00	Low
5/8/2018	Robert W. Baird	Boost Price Target	Outperform ➝ Outperform	$150.00	Low
5/8/2018	Leerink Swann	Set Price Target	Hold	$150.00	High
5/8/2018	Evercore ISI	Upgrade	In-Line ➝ Outperform	$140.00	High
4/30/2018	Citigroup	Lower Price Target	Neutral ➝ Neutral	$148.00 ➝ $140.00	High
4/24/2018	JPMorgan Chase & Co.	Initiated Coverage	Neutral ➝ Neutral	$148.00 ➝ $159.00	Low
2/27/2018	Bank of America	Initiated Coverage	Neutral ➝ Neutral	$147.00	Low
2/16/2018	Piper Jaffray Companies	Reiterated Rating	Buy	$160.00	Low
2/5/2018	SunTrust Banks	Boost Price Target	Buy	$180.00	High
2/1/2018	Canaccord Genuity	Boost Price Target	Hold ➝ Hold	$123.00 ➝ $137.00	High
1/12/2018	KeyCorp	Reiterated Rating	Buy	$152.00	High
10/23/2017	Wells Fargo & Co	Lower Price Target	Outperform	$190.00 ➝ $155.00	N/A
10/23/2017	First Analysis	Upgrade	Underweight ➝ Equal Weight	$125.00 ➝ $127.00	N/A
10/20/2017	Oppenheimer	Reiterated Rating	Buy	$184.00	N/A
8/2/2017	Morgan Stanley	Reiterated Rating	Equal Weight	$108.00 ➝ $125.00	Low
7/31/2017	Cowen	Downgrade	Outperform ➝ Market Perform	$127.00 ➝ $133.00	Medium
7/24/2017	UBS	Reiterated Rating	Buy ➝ Positive	$157.00 ➝ $175.00	Low
7/21/2017	William Blair	Reiterated Rating	Market Perform		Medium
7/7/2017	Dougherty & Co	Downgrade	Buy ➝ Neutral		High
7/7/2017	Argus	Initiated Coverage	Hold		High
6/16/2017	Stifel Nicolaus	Reiterated Rating	Hold	$106.00 ➝ $151.00	Low
5/1/2017	Barclays	Set Price Target	Underweight	$97.00 ➝ $88.00	Medium
1/4/2017	Pacific Crest	Upgrade	Overweight	$140.00	N/A
7/22/2016	FBR & Co	Lower Price Target	Market Perform	$145.00 ➝ $140.00	N/A

(Data available from 5/25/2016 forward)

athenahealth (NASDAQ:ATHN) Earnings History and Estimates Chart

Earnings by Quarter for athenahealth (NASDAQ:ATHN)

athenahealth (NASDAQ:ATHN) Earnings Estimates

2018 EPS Consensus Estimate: $1.41

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	1	$0.22	$0.22	$0.22
Q2 2018	1	$0.33	$0.33	$0.33
Q3 2018	1	$0.34	$0.34	$0.34
Q4 2018	1	$0.52	$0.52	$0.52

athenahealth (NASDAQ ATHN) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
7/18/2018		$0.95					N/A
4/26/2018	Q1 2018	$0.72	$1.25	$318.13 million	$329.40 million	View	N/A
2/1/2018	Q4 2017	$0.63	$1.11	$319.64 million	$329.20 million	View	Listen
10/19/2017	Q3 2017	$0.50	$0.56	$310.52 million	$304.60 million	View	N/A
7/20/2017	Q2 2017	$0.39	$0.51	$298.68 million	$301.10 million	View	N/A
4/27/2017	Q1 2017	$0.11	$0.10	$296.49 million	$285.40 million	View	N/A
2/2/2017	Q4 2016	$0.5080	$0.62	$303.72 million	$288.20 million	View	Listen
10/20/2016	Q3	$0.47	$0.60	$280.17 million	$276.67 million	View	Listen
7/21/2016	Q2	$0.42	$0.34	$274.07 million	$261.90 million	View	Listen
4/28/2016	Q1	$0.26	$0.34	$248.49 million	$256.15 million	View	Listen
2/4/2016	Q415	$0.41	$0.45	$257.68 million	$257.50 million	View	N/A
10/22/2015	Q315	$0.26	$0.36	$233.03 million	$236.10 million	View	Listen
7/23/2015	Q215	$0.25	$0.32	$227.08 million	$224.70 million	View	Listen
4/30/2015	Q115	($0.10)	$0.24	$205.24 million	$206.40 million	View	Listen
2/5/2015	Q414	$0.39	$0.58	$207.99 million	$213.20 million	View	N/A
10/16/2014	Q314	$0.27	$0.27	$190.40 million	$190.40 million	View	Listen
7/17/2014	Q214	$0.22	$0.32	$182.14 million	$185.90 million	View	N/A
4/17/2014	Q114	($0.01)	$0.12	$170.03 million	$163.00 million	View	Listen
2/6/2014	Q413	$0.45	$0.57	$168.39 million	$171.60 million	View	N/A
10/17/2013	Q313	$0.31	$0.29	$154.80 million	$151.50 million	View	N/A
7/18/2013	Q2 2013	$0.22	($0.08)	$148.24 million	$149.30 million	View	Listen
5/2/2013	Q1 2013	$0.23	$0.38	$121.05 million	$125.60 million	View	Listen
2/7/2013	Q4 2012	$0.28	$0.29	$116.97 million	$116.30 million	View	Listen
10/18/2012		$0.26	$0.30			View	N/A
7/19/2012		$0.23	$0.24			View	N/A
4/26/2012		$0.17	$0.17			View	N/A
2/15/2012		$0.23	$0.26			View	N/A
10/20/2011		$0.20	$0.24			View	N/A
7/21/2011		$0.19	$0.22			View	N/A
4/28/2011		$0.13	$0.17			View	N/A
2/17/2011		$0.20	$0.28			View	N/A
10/21/2010	Q3 2010	$0.08	$0.11			View	N/A
7/22/2010	Q2 2010	$0.06	$0.04			View	N/A
4/29/2010	Q1 2010	$0.10	$0.02			View	N/A
3/15/2010	Q4 2009	$0.12	$0.12			View	N/A
10/29/2009	Q3 2009	$0.10	$0.08			View	N/A
8/5/2009	Q2 2009	$0.09	$0.09			View	N/A
4/30/2009	Q1 2009	$0.10	$0.07			View	N/A
2/26/2009	Q4 2008	$0.13	$0.11			View	N/A
11/6/2008	Q3 2008	$0.09	$0.11			View	N/A
8/4/2008	Q2 2008	$0.07	$0.08			View	N/A
5/6/2008	Q1 2008	$0.06	$0.05			View	N/A
3/5/2008	Q4 2007	$0.06	$0.06			View	N/A

(Earnings results data provided by Zacks Investment Research)

athenahealth (NASDAQ:ATHN) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

athenahealth (NASDAQ ATHN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.90%

Insider Trading History for athenahealth (NASDAQ:ATHN)

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

athenahealth (NASDAQ ATHN) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/16/2018	Daniel P Haley	Insider	Sell	1,107	$149.40	$165,385.80	12,383
5/7/2018	Jonathan Bush	CEO	Sell	25,000	$155.00	$3,875,000.00
5/7/2018	Jonathan D. Porter	SVP	Sell	422	$153.30	$64,692.60
5/1/2018	Jonathan Bush	CEO	Sell	5,000	$124.01	$620,050.00	340,106
4/26/2018	Jonathan D. Porter	SVP	Sell	150	$143.41	$21,511.50
4/2/2018	Jonathan Bush	CEO	Sell	5,000	$140.47	$702,350.00	340,106
3/26/2018	Jonathan D. Porter	SVP	Sell	150	$141.00	$21,150.00
3/2/2018	Bradford Kyle Armbrester	SVP	Sell	2,235	$138.70	$309,994.50	10,146
3/2/2018	Timothy John O'brien	CMO	Sell	3,064	$137.27	$420,595.28	11,320
3/1/2018	Daniel P Haley	Insider	Sell	1,153	$136.83	$157,764.99	12,436
3/1/2018	Jonathan Bush	CEO	Sell	250	$139.27	$34,817.50	321,533
2/27/2018	Jeffrey R. Immelt	Director	Buy	3,600	$141.04	$507,744.00
2/27/2018	Jonathan Bush	CEO	Sell	4,750	$141.11	$670,272.50	320,557
2/26/2018	Jonathan D. Porter	SVP	Sell	150	$139.87	$20,980.50
2/20/2018	Jeffrey R Immelt	Director	Buy	7,200	$138.44	$996,768.00	678
2/5/2018	Jonathan Bush	CEO	Sell	25,000	$145.00	$3,625,000.00
2/2/2018	Brandon H Hull	Director	Sell	653	$133.00	$86,849.00	5,230
2/1/2018	Jonathan Bush	CEO	Sell	5,000	$122.69	$613,450.00	320,807
1/26/2018	Jonathan D. Porter	SVP	Sell	150	$128.26	$19,239.00
1/2/2018	David Eric Robinson	Director	Sell	5,000	$133.94	$669,700.00	8,596
12/29/2017	Jonathan D Porter	SVP	Sell	150	$134.52	$20,178.00
12/29/2017	Jonathan D. Porter	SVP	Sell	150	$134.52	$20,178.00
12/26/2017	Amy Abernethy	Director	Sell	500	$134.18	$67,090.00	4,045
12/26/2017	Amy Abernethy	Director	Sell	500	$134.18	$67,090.00	4,045
12/26/2017	Jonathan Bush	CEO	Sell	30,000	$134.80	$4,044,000.00	320,807
12/26/2017	Jonathan Bush	CEO	Sell	30,000	$134.80	$4,044,000.00	320,807
12/1/2017	Brandon H. Hull	Director	Sell	800	$132.97	$106,376.00
11/20/2017	Brandon H. Hull	Director	Sell	800	$130.00	$104,000.00
10/27/2017	Bradford Kyle Armbrester	SVP	Sell	1,000	$128.56	$128,560.00
10/20/2017	Brandon H. Hull	Director	Sell	800	$130.00	$104,000.00
10/2/2017	Daniel P Haley	Insider	Sell	1,583	$124.56	$197,178.48	13,408
10/2/2017	Jonathan Bush	CEO	Sell	4,000	$124.17	$496,680.00	319,807
9/15/2017	Jonathan D. Porter	SVP	Sell	300	$130.38	$39,114.00
9/1/2017	Brandon H. Hull	Director	Sell	800	$140.95	$112,760.00
9/1/2017	Jonathan Bush	CEO	Sell	4,000	$139.77	$559,080.00	319,807
8/15/2017	Jonathan D. Porter	SVP	Sell	300	$142.88	$42,864.00
8/1/2017	Brandon H. Hull	Director	Sell	800	$140.01	$112,008.00
8/1/2017	Jonathan Bush	CEO	Sell	4,000	$143.31	$573,240.00	319,807
7/21/2017	Jonathan D. Porter	SVP	Sell	422	$154.00	$64,988.00
7/17/2017	Jonathan D. Porter	SVP	Sell	300	$143.13	$42,939.00
7/3/2017	Brandon H. Hull	Director	Sell	800	$140.81	$112,648.00
7/3/2017	Jonathan Bush	CEO	Sell	4,000	$140.52	$562,080.00	319,807
6/15/2017	Jonathan D. Porter	SVP	Sell	300	$142.27	$42,681.00
6/5/2017	Karl Stubelis	CFO	Sell	3,952	$138.98	$549,248.96	21,810
5/18/2017	Bradford Kyle Armbrester	SVP	Sell	2,431	$130.00	$316,030.00
5/18/2017	Brandon H. Hull	Director	Sell	1,600	$130.00	$208,000.00
5/18/2017	Jonathan Bush	CEO	Sell	4,000	$125.85	$503,400.00	319,807
5/15/2017	Jonathan D. Porter	SVP	Sell	300	$109.48	$32,844.00
4/25/2017	Jonathan Bush	CEO	Sell	8,000	$120.00	$960,000.00	319,807
1/27/2017	John A Kane	Director	Sell	2,875	$123.11	$353,941.25	8,958
1/12/2017	Jonathan Bush	CEO	Sell	4,000	$120.00	$480,000.00	312,109
12/15/2016	Amy Abernethy	Director	Sell	1,000	$117.15	$117,150.00	2,649
12/15/2016	Ed Park	COO	Sell	2,500	$117.15	$292,875.00	13,219
12/15/2016	Jonathan Bush	CEO	Sell	8,000	$120.00	$960,000.00	312,109
12/1/2016	Ed Park	COO	Sell	1,500	$94.60	$141,900.00	10,719
10/27/2016	John A. Kane	Director	Sell	5,750	$122.63	$705,122.50
10/10/2016	Bradford Kyle Armbrester	SVP	Sell	2,545	$130.00	$330,850.00
10/10/2016	Brandon H Hull	Director	Sell	2,400	$130.00	$312,000.00	3,987
10/3/2016	Daniel P Haley	SVP	Sell	2,109	$124.43	$262,422.87	3,195
10/3/2016	Jonathan Bush	CEO	Sell	4,000	$124.34	$497,360.00	312,109
9/7/2016	Karl Stubelis	VP	Sell	928	$123.36	$114,478.08	1,375
8/15/2016	Ed Park	COO	Sell	4,000	$124.20	$496,800.00	20,719
8/1/2016	Jonathan Bush	CEO	Sell	4,000	$128.19	$512,760.00	312,109
7/27/2016	John A Kane	Director	Sell	2,875	$128.81	$370,328.75	10,708
7/6/2016	Ed Park	COO	Sell	1,500	$136.85	$205,275.00	18,819
7/1/2016	Brandon H Hull	Director	Sell	800	$137.48	$109,984.00	6,387
7/1/2016	Jonathan Bush	CEO	Sell	4,000	$138.21	$552,840.00	312,109
6/2/2016	Brandon H Hull	Director	Sell	800	$130.00	$104,000.00	7,187
6/1/2016	Ed Park	COO	Sell	1,500	$125.82	$188,730.00	19,819
6/1/2016	Jonathan Bush	CEO	Sell	4,000	$125.97	$503,880.00	312,109
5/4/2016	Ed Park	COO	Sell	1,500	$127.81	$191,715.00	21,819
5/2/2016	Brandon H Hull	Director	Sell	800	$132.74	$106,192.00	7,987
5/2/2016	Jonathan Bush	CEO	Sell	4,000	$132.09	$528,360.00	312,109
5/2/2016	Kristi Ann Matus	EVP	Sell	415	$133.27	$55,307.05	34,116
4/25/2016	Karl Stubelis	VP	Sell	547	$138.64	$75,836.08
4/6/2016	Ed Park	COO	Sell	1,500	$139.15	$208,725.00	22,919
4/1/2016	Brandon H Hull	Director	Sell	800	$137.72	$110,176.00	8,787
4/1/2016	Jonathan Bush	CEO	Sell	4,000	$138.44	$553,760.00	307,408
4/1/2016	Kristi Ann Matus	EVP	Sell	415	$138.61	$57,523.15	34,531
3/3/2016	Bradford Kyle Armbrester	SVP	Sell	1,369	$132.04	$180,762.76
3/1/2016	Brandon H Hull	Director	Sell	1,600	$130.00	$208,000.00	8,687
3/1/2016	Daniel P Haley	SVP	Sell	1,279	$130.64	$167,088.56	365
3/1/2016	Ed Park	COO	Sell	1,500	$131.66	$197,490.00	26,270
3/1/2016	Jonathan Bush	CEO	Sell	4,000	$129.61	$518,440.00	312,109
3/1/2016	Kristi Ann Matus	EVP	Sell	415	$129.53	$53,754.95	33,357
3/1/2016	Timothy John O'brien	CMO	Sell	846	$132.25	$111,883.50	62
2/16/2016	Bradford Kyle Armbrester	SVP	Sell	1,657	$127.11	$210,621.27	2,500
2/16/2016	Timothy John O'brien	CMO	Sell	816	$127.08	$103,697.28	1,250
2/3/2016	Ed Park	COO	Sell	1,500	$140.61	$210,915.00	27,433
2/1/2016	Jonathan Bush	CEO	Sell	4,000	$140.14	$560,560.00	308,109
2/1/2016	Kristi Ann Matus	EVP	Sell	415	$141.08	$58,548.20	33,772
1/27/2016	John A. Kane	Director	Sell	2,875	$140.81	$404,828.75	6,133
1/6/2016	Ed Park	COO	Sell	1,500	$161.89	$242,835.00	28,933
1/4/2016	Jonathan Bush	CEO	Sell	4,000	$156.79	$627,160.00	308,109
1/4/2016	Kristi Ann Matus	EVP	Sell	415	$159.06	$66,009.90	34,187
12/2/2015	Ed Park	COO	Sell	1,500	$166.81	$250,215.00	30,433
11/20/2015	Stephen N Kahane	EVP	Sell	1,280	$157.80	$201,984.00	17,829
11/6/2015	Stephen N Kahane	EVP	Sell	5,000	$159.51	$797,550.00	19,109
11/4/2015	Ed Park	COO	Sell	1,500	$162.32	$243,480.00	31,933
11/3/2015	Jonathan Bush	CEO	Sell	14,750	$156.50	$2,308,375.00	311,234
10/27/2015	John A. Kane	Director	Sell	2,875	$150.44	$432,515.00	6,133
10/23/2015	Jonathan Bush	CEO	Sell	20,000	$157.50	$3,150,000.00	311,234
10/23/2015	Robert Cosinuke	CMO	Sell	1,211	$159.02	$192,573.22	40,322
10/23/2015	Stephen N Kahane	EVP	Sell	5,000	$150.50	$752,500.00	24,109
10/20/2015	Stephen N Kahane	EVP	Sell	2,000	$132.88	$265,760.00	29,109
10/7/2015	Ed Park	COO	Sell	1,500	$134.23	$201,345.00	33,433
10/2/2015	Jonathan Bush	CEO	Sell	1,000	$130.74	$130,740.00	311,234
9/15/2015	Stephen N Kahane	EVP	Sell	2,000	$135.77	$271,540.00	31,031
9/2/2015	Ed Park	COO	Sell	1,500	$129.64	$194,460.00	34,933
9/2/2015	Jonathan Bush	CEO	Sell	1,000	$131.09	$131,090.00	311,234
8/18/2015	Stephen N Kahane	EVP	Sell	2,000	$141.49	$282,980.00
7/24/2015	David Eric Robinson	Director	Sell	10,000	$130.00	$1,300,000.00
7/21/2015	Stephen N Kahane	EVP	Sell	2,000	$117.32	$234,640.00
7/2/2015	Jonathan Bush	CEO	Sell	1,000	$114.17	$114,170.00
6/2/2015	Jonathan Bush	CEO	Sell	1,000	$115.32	$115,320.00
4/27/2015	John A Kane	Director	Sell	2,875	$125.35	$360,381.25
4/14/2015	Karl Stubelis	VP	Sell	1,115	$126.28	$140,802.20
4/2/2015	Jonathan Bush	CEO	Sell	1,000	$118.77	$118,770.00
3/10/2015	James L Mann	Director	Sell	13,106	$121.27	$1,589,364.62
3/3/2015	Robert Cosinuke	CMO	Sell	6,000	$128.15	$768,900.00
2/24/2015	Jonathan Bush	CEO	Sell	2,499	$130.23	$325,444.77
2/18/2015	Jonathan Bush	CEO	Sell	2,498	$132.04	$329,835.92
2/10/2015	Jonathan Bush	CEO	Sell	7,495	$135.82	$1,017,970.90
2/5/2015	David Eric Robinson	Director	Sell	25,000	$143.17	$3,579,250.00
2/3/2015	Robert Cosinuke	CMO	Sell	6,000	$139.06	$834,360.00
1/5/2015	David Eric Robinson	Director	Sell	25,000	$145.14	$3,628,500.00
1/5/2015	Robert Cosinuke	CMO	Sell	6,000	$145.18	$871,080.00
12/22/2014	Robert Cosinuke	CMO	Sell	6,000	$139.32	$835,920.00
12/2/2014	Jonathan Bush	CEO	Sell	1,000	$116.55	$116,550.00
10/10/2014	Robert Cosinuke	CMO	Sell	3,000	$123.78	$371,340.00
10/2/2014	Jonathan Bush	CEO	Sell	1,000	$128.41	$128,410.00
9/10/2014	Robert Cosinuke	CMO	Sell	6,000	$138.08	$828,480.00
8/11/2014	Robert Cosinuke	CMO	Sell	6,000	$129.43	$776,580.00
8/4/2014	Jonathan Bush	CEO	Sell	1,000	$121.58	$121,580.00
7/10/2014	Robert Cosinuke	CMO	Sell	6,000	$120.10	$720,600.00
7/2/2014	Jonathan Bush	CEO	Sell	1,000	$129.45	$129,450.00
7/1/2014	Stephen N Kahane	Insider	Sell	5,000	$127.60	$638,000.00
6/12/2014	David Eric Robinson	Director	Sell	30,000	$124.12	$3,723,600.00
6/10/2014	Robert Cosinuke	CMO	Sell	6,000	$125.07	$750,420.00
6/2/2014	Jonathan Bush	CEO	Sell	1,000	$125.82	$125,820.00
6/2/2014	Stephen N Kahane	Insider	Sell	5,000	$126.42	$632,100.00
5/2/2014	Jonathan Bush	CEO	Sell	1,000	$123.21	$123,210.00	311,234
5/1/2014	Stephen Kahane	Insider	Sell	5,000	$121.96	$609,800.00	64,285
4/16/2014	Stephen Kahane	Insider	Sell	10,000	$143.96	$1,439,600.00	69,285
4/14/2014	David Eric Robinson	Director	Sell	60,000	$140.61	$8,436,600.00	3,692
4/10/2014	Robert Cosinuke	CMO	Sell	6,000	$151.14	$906,840.00	44,804
4/2/2014	Jonathan Bush	CEO	Sell	1,000	$161.74	$161,740.00	311,234
3/10/2014	Robert Cosinuke	CMO	Sell	6,000	$181.60	$1,089,600.00	46,277
2/18/2014	Timothy Adams	CFO	Sell	30,000	$194.58	$5,837,400.00	40,327
2/12/2014	Dev Ittycheria	Director	Sell	2,000	$181.17	$362,340.00	8,574
2/10/2014	Robert Cosinuke	CMO	Sell	6,000	$172.72	$1,036,320.00	53,321
2/3/2014	Daniel Orenstein	SVP	Sell	1,000	$146.73	$146,730.00	31,262
2/3/2014	David Eric Robinson	Director	Sell	4,000	$146.86	$587,440.00	2,058
1/10/2014	Robert Cosinuke	CMO	Sell	6,000	$132.92	$797,520.00	53,321
1/3/2014	David Eric Robinson	Director	Sell	4,000	$131.86	$527,440.00	2,058
12/10/2013	Robert Cosinuke	CMO	Sell	6,000	$132.77	$796,620.00	53,321
12/3/2013	David Eric Robinson	Director	Sell	4,000	$132.48	$529,920.00	2,058
12/2/2013	Jonathan Bush	CEO	Sell	1,000	$132.24	$132,240.00	311,759
11/4/2013	David Eric Robinson	Director	Sell	4,000	$137.26	$549,040.00
11/4/2013	Jonathan Bush	CEO	Sell	1,000	$137.26	$137,260.00
11/1/2013	Daniel H Orenstein	SVP	Sell	1,000	$133.15	$133,150.00
10/21/2013	Timothy M Adams	CFO	Sell	20,000	$138.39	$2,767,800.00
10/18/2013	Ed Park	COO	Sell	10,021	$123.36	$1,236,190.56
10/18/2013	Jonathan Bush	CEO	Sell	20,000	$120.00	$2,400,000.00
10/10/2013	Robert Cosinuke	CMO	Sell	6,000	$108.21	$649,260.00	53,321
10/3/2013	David Eric Robinson	Director	Sell	4,000	$111.01	$444,040.00
10/2/2013	Jonathan Bush	CEO	Sell	1,000	$110.16	$110,160.00
9/10/2013	Robert Cosinuke	CMO	Sell	6,000	$109.68	$658,080.00
9/3/2013	Daniel Orenstein	SVP	Sell	1,000	$106.73	$106,730.00	31,262
9/3/2013	David Eric Robinson	Director	Sell	4,000	$106.53	$426,120.00	2,058
9/3/2013	Jonathan Bush	CEO	Sell	22,105	$106.45	$2,353,077.25	302,231
8/19/2013	John Kane	Director	Sell	2,000	$111.23	$222,460.00	5,052
8/15/2013	John Kane	Director	Sell	5,000	$110.03	$550,150.00	5,052
8/12/2013	Robert Cosinuke	CMO	Sell	6,000	$115.72	$694,320.00	53,321
8/5/2013	David Eric Robinson	Director	Sell	4,000	$114.01	$456,040.00
8/1/2013	Daniel H Orenstein	SVP	Sell	1,000	$113.73	$113,730.00
8/1/2013	Jonathan Bush	CEO	Sell	5,000	$113.94	$569,700.00	302,231
7/12/2013	Timothy M Adams	CFO	Sell	10,000	$106.14	$1,061,400.00
7/11/2013	David Eric Robinson	Director	Sell	4,000	$90.00	$360,000.00
7/10/2013	Robert Cosinuke	CMO	Sell	6,000	$87.06	$522,360.00
7/1/2013	Daniel H Orenstein	SVP	Sell	1,000	$85.01	$85,010.00
7/1/2013	Jonathan Bush	CEO	Sell	5,000	$85.39	$426,950.00
6/17/2013	David Eric Robinson	Director	Sell	4,000	$90.00	$360,000.00
6/10/2013	Robert Cosinuke	CMO	Sell	6,000	$85.74	$514,440.00
6/3/2013	Daniel H Orenstein	SVP	Sell	1,000	$84.22	$84,220.00
6/3/2013	Jonathan Bush	CEO	Sell	5,000	$84.39	$421,950.00
5/10/2013	Robert Cosinuke	CMO	Sell	6,000	$84.80	$508,800.00
5/1/2013	Jonathan Bush	CEO	Sell	5,000	$95.70	$478,500.00
2/26/2013	David Eric Robinson	Director	Sell	10,000	$90.13	$901,300.00
8/10/2012	Robert Cosinuke	CMO	Sell	3,000	$92.35	$277,050.00

(Data available from 1/1/2013 forward)

athenahealth (NASDAQ ATHN) News Headlines

Source:

Date	Headline
	Brainstorm Health: Ingestible Gut Bacteria Monitor, Athenahealth Pressure, Open Offices and Biopharma fortune.com - May 25 at 6:08 PM
	Elliott Calls For Athenahealth To Commence Full Process Without Further Delay www.nasdaq.com - May 24 at 5:53 PM
	Elliott Pushes Athenahealth To Commence A Sale Process: 'Shareholders Have Spoken' feeds.benzinga.com - May 24 at 3:18 PM
	Austin 'key' to Athenahealth's growth as tech company hires finance.yahoo.com - May 23 at 5:46 PM
	Athenahealth could fetch $170/share - Deutsche Bank seekingalpha.com - May 22 at 5:16 PM
	athenahealth (ATHN) PT Raised to $170.00 at Deutsche Bank www.americanbankingnews.com - May 22 at 12:30 PM
	Austin 'key' to Athenahealth's growth as tech company hires www.bizjournals.com - May 21 at 5:19 PM
	athenahealth (ATHN) Receives Average Rating of "Hold" from Brokerages www.americanbankingnews.com - May 21 at 11:35 AM
	BRIEF-Janus Henderson Reports 11.9 Percent Stake In athenahealth www.reuters.com - May 19 at 8:02 AM
	athenahealth (ATHN) Downgraded by ValuEngine to Hold www.americanbankingnews.com - May 18 at 11:48 PM
	Today’s Free Research Report Coverage on Evolent Health and Three More Healthcare Information Services Stocks finance.yahoo.com - May 18 at 8:11 AM
	athenahealth (ATHN) Insider Sells $165,385.80 in Stock www.americanbankingnews.com - May 17 at 8:17 PM
	athenahealth (ATHN) PT Raised to $160 at RBC Capital www.streetinsider.com - May 17 at 7:13 PM
	athenahealth's (ATHN) Sector Perform Rating Reaffirmed at Royal Bank of Canada www.americanbankingnews.com - May 17 at 5:53 PM
	athenahealth (ATHN) PT Set at $160.00 by Jefferies Group www.americanbankingnews.com - May 17 at 2:59 PM
	athenahealth (ATHN) Expected to Post Quarterly Sales of $334.11 Million www.americanbankingnews.com - May 17 at 2:20 AM
	Brokerages Anticipate athenahealth (ATHN) to Post $0.93 Earnings Per Share www.americanbankingnews.com - May 15 at 7:14 PM
	athenahealth (ATHN) Lowered to "Hold" at Berenberg Bank www.americanbankingnews.com - May 15 at 2:25 PM
	Will athenahealth Be the Next Big Healthcare Deal? www.fool.com - May 14 at 6:35 PM
	Getting a Deal Done on athenahealth Might Be Tough www.fool.com - May 14 at 6:35 PM
	BRIEF-Elliott Management Releases Letter To The Board Of Athenahealth www.reuters.com - May 14 at 5:30 PM
	Elliott Urges Athenahealth Board To Engage In Talks Regarding Its Proposal www.nasdaq.com - May 14 at 5:30 PM
	athenahealth (ATHN) Receives "Hold" Rating from Cantor Fitzgerald www.americanbankingnews.com - May 14 at 4:55 PM
	Form 3 ATHENAHEALTH INC For: May 01 Filed by: Connor Bret www.streetinsider.com - May 12 at 8:10 AM
	Who Else Could Buy athenahealth? finance.yahoo.com - May 10 at 8:07 AM
	Investors Buy High Volume of athenahealth Call Options (ATHN) www.americanbankingnews.com - May 10 at 2:40 AM
	DIGITAL HEALTH BRIEFING: Athenahealth gets $7B bid — Teladoc taps mental health space for growth — US health ... www.businessinsider.com - May 9 at 5:49 PM
	Why Athenahealth (ATHN) Is a Major Medtech Acquisition Target finance.yahoo.com - May 9 at 8:05 AM
	athenahealth (ATHN) Rating Increased to Buy at ValuEngine www.americanbankingnews.com - May 8 at 11:54 PM
	Insider Selling: athenahealth (ATHN) SVP Sells 422 Shares of Stock www.americanbankingnews.com - May 8 at 8:18 PM
	athenahealth (ATHN) CEO Sells $3,875,000.00 in Stock www.americanbankingnews.com - May 8 at 7:20 PM
	athenahealth (ATHN) PT Raised to $160 at Baird Following Acquisition Offer by Elliot Management www.streetinsider.com - May 8 at 5:54 PM
	athenahealth (ATHN) PT Set at $150.00 by Leerink Swann www.americanbankingnews.com - May 8 at 3:45 PM
	athenahealth (ATHN) PT Set at $130.00 by Jefferies Group www.americanbankingnews.com - May 8 at 3:28 PM
	athenahealth (ATHN) Stock Rating Upgraded by Evercore ISI www.americanbankingnews.com - May 8 at 1:41 PM
	Robert W. Baird Boosts athenahealth (ATHN) Price Target to $160.00 www.americanbankingnews.com - May 8 at 11:02 AM
	UPDATE: Evercore ISI Upgrades athenahealth (ATHN) to Outperform Following Takeover Bid from Elliot Management www.streetinsider.com - May 8 at 8:04 AM
	Here's what led up to Elliott's takeover bid for athenahealth www.bizjournals.com - May 8 at 8:04 AM
	Elliott Management makes unsolicited bid for Athenahealth www.reuters.com - May 8 at 8:04 AM
	[$$] Elliott Looks to Take Athenahealth Private finance.yahoo.com - May 8 at 8:04 AM
	Elliott bid for athenahealth buoys medical IT players seekingalpha.com - May 7 at 5:49 PM
	Elliott Looks to Take Athenahealth Private www.wsj.com - May 7 at 5:49 PM
	Elliott to make all-cash offer for Athenahealth, say sources www.cnbc.com - May 7 at 5:49 PM
	Elliott bids for Athenahealth in all-cash offer www.cnbc.com - May 7 at 5:49 PM
	Here's Why Athenahealth Is Skyrocketing Today www.fool.com - May 7 at 12:30 PM
	athenahealth to Review Unsolicited Acquisition Proposal from Elliott Management www.prnewswire.com - May 7 at 10:52 AM
	Elliott Management Makes $160-Per-Share Takeover Offer For Athenahealth feeds.benzinga.com - May 7 at 10:52 AM
	Form 4 ATHENAHEALTH INC For: May 01 Filed by: Bush Jonathan www.streetinsider.com - May 2 at 8:09 AM
	athenahealth (ATHN) PT Lowered to $155 at Piper Jaffray Following 1Q Conference Call www.streetinsider.com - May 2 at 8:09 AM
	athenahealth (ATHN) CEO Jonathan Bush Sells 5,000 Shares www.americanbankingnews.com - May 1 at 10:12 PM